DICE Therapeutics Inc.

47.55
0.03 (0.06%)
At close: Aug 08, 2023, 8:00 PM

DICE Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
-104.24M -90.94M -83.89M -76.86M -73.64M -59.48M -48.96M -39.89M -28.57M -21.21M -13.15M -6.02M
2.52M 2.53M 2.42M 1.97M 1.52M 1M 661K 677K 700K 521K 341K 169K
17.2M 15.9M 12.82M 11.16M 10.86M 7.04M 5.58M 4.05M 1.04M 646K 299K 149K
2.01M 650K -191K 2.26M 3.76M 1.26M 2.42M 606K -634K 357K 514K 409K
-4.69M -1.05M 1.34M 1.22M 2.53M 1.81M 1.78M 1.67M 301K 82K 90K 38K
n/a n/a 329K 464K 1.84M 1.84M 1.51M 1.38M n/a n/a n/a n/a
4.97M 962K 2.64M 1.33M 3.97M 3.84M 1.65M 3.04M -113K 1.28M 1.73M 549K
-84.23M -72.59M -64.32M -60.84M -54.44M -45.46M -39.29M -30.46M -26.64M -18.69M -10.69M -5.11M
-2.99M -2.05M -2.24M -2M -1.59M -738K -718K -539K -418K -382K -17K n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-525.43M -516.08M -183.86M -330.75M -301.63M -259.89M -218.47M -26.97M -26.96M -24.08M -1K -1K
298.19M 271.24M 228.98M 134.43M 60.63M 32.57M 14.56M 2.7M 3M 3M 3M 3M
44.61M 44.61M 44.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a
-185.63M -202.28M 87.49M -198.32M -242.59M -228.06M -204.62M -24.81M -24.38M -21.46M 2.98M 3M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
4.83B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-4.5B 322.65M 322.25M -4.33M 298.15M 302.67M 300.25M 356.11M 53.28M 51.43M 53.95M -361K
326.56M 322.65M 322.25M -4.33M 298.15M 302.67M 300.25M 356.11M 53.28M 51.43M 53.95M -361K
56.7M 47.78M 345.42M -263.49M 1.11M 29.15M 56.34M 300.84M 2.26M 11.28M 46.25M -2.47M
-87.22M -74.65M -66.56M -62.84M -56.03M -46.2M -40.01M -31M -27.06M -19.07M -10.71M -5.11M